PharmAlliance is committed to supporting the business development of the pharmaceutical and related industries by providing complete and comprehensive expertise for achieving global market presence
  Income Tax Benefits in India for Expenses Incurred on Regulatory Approvals and Clinical
  "Indian Pharmaceutical Industry - Issues & Strategies in the Post - GATT / WTO Era"
    Address by Mr. Asaf Shamsi. in the Seminar on "Impact of WTO on Industry" organized by
    the Confederation of Indian Industry (CII) on August 17, 2000, at Baroda, India
"Enhancing Global Reach of the Indian Pharmaceutical Industry"
Seminar on Market Penetration and Regulatory Approvals in Europe and USA jointly organized by
the Confederation of Indian Industry (CII) and PharmAlliance at the Indian Institute of
    Management, Ahmedabad (IIMA) on October 25, 2000. PharmAlliance, India's pioneering international regulatory affairs and market
    development consulting firm, has joined hands with reputed architectural and ...
  Mondaq: India - Litigation and Arbitration - "TRIPS: The Post-Doha Divide - Issues for LDCs"
    by Mr. Asaf Shamsi, PharmAlliance - TRIPs, the intellectual property component of the ...
    This article was originally written and published at the 54th Indian Pharmaceutical Congress in
    Pune, Maharashtra, in December, 2002, and was subsequently syndicated by Mondaq in January,
  Contract Pharma Magazine: "Outsourcing CMC Regulatory Affairs Services - How to get the
    most from Regulatory Affairs Service Providers"
Powered by : © Copyright 2008 • PharmAlliance • All rights reserved. Top